Patient Guide: An Observational Study to Assess Ubrogepant Tablets and Atogepant Tablets to Treat Migraine in Adult Participants

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 11 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT05827887
Status: 🟢 Enrolling Now
Condition: Migraine
Phase: Research Study

Where You Can Participate

This study is available at 11 locations across the country.

Top locations include:
  • • Ashdod, HaDarom
  • • Be'er Sheva, HaDarom
  • • Holon, HaMerkaz
  • • And 8 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

An Observational Study to Assess Ubrogepant Tablets and Atogepant Tablets to Treat Migraine in Adult Participants - Join Clinical Trial NCTNCT05827887

How to Join This Clinical Trial - NCTNCT05827887

Learn how to participate in this clinical trial studying an investigational therapy for Migraine. This study is currently enrolling participants.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Migraine. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Migraine
Treatment Being Tested
Investigational treatment
Study Phase
Clinical trial phase - Research study
Enrollment Status
Currently enrolling participants
Study Identifier
NCTNCT05827887 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 11 locations. Find a study site near you:

Clinical Research Site

Ashdod, HaDarom 7747629 - Israel

Status: RECRUITING

Clinical Research Site

Be'er Sheva, HaDarom 8410101 - Israel

Status: COMPLETED

Clinical Research Site

Holon, HaMerkaz 5822012 - Israel

Status: RECRUITING

Clinical Research Site

Kfar Saba, HaMerkaz 4420123 - Israel

Status: RECRUITING

Clinical Research Site

Kfar Saba, HaMerkaz 4428164 - Israel

Status: RECRUITING

Clinical Research Site

Safed, HaTsafon 13100 - Israel

Status: RECRUITING

Clinical Research Site

Ramat Gan, Tel-Aviv 5265601 - Israel

Status: RECRUITING

Clinical Research Site

Tel Aviv, Tel-Aviv 6423906 - Israel

Status: RECRUITING

Clinical Research Site

Jerusalem, Yerushalayim 91031 - Israel

Status: RECRUITING

Clinical Research Site

Gani Tikva, 5591236 - Israel

Status: RECRUITING

And 1 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this clinical trial for Migraine:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships